GuangYuYuan Chinese Herbal Medicine , Ltd. EBIT

As of the most recent data (June 2026), 600771.SS shows a EBIT of $95M. That compares with $99M in the prior-year period — down 3.9% year over year. That is above the sector sector average of $-25M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 600771.SS's EBIT is now $95M (was $99M) — a 3.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GuangYuYuan Chinese Herbal Medicine , Ltd. is outperforming or lagging.

The its sector sector average EBIT is about $-25M. GuangYuYuan Chinese Herbal Medicine , Ltd. is at $95M, which is higher that average. That is roughly 476.5% above the sector mean. Use the comparison chart on this page to see how 600771.SS stacks up against individual peers as well.

Tracking 600771.SS's ebit over time shows whether GuangYuYuan Chinese Herbal Medicine , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $95M That compares with $99M in the prior-year period — down 3.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has GuangYuYuan Chinese Herbal Medicine , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $95M) with ownership activity and broader fundamentals.